Prelude Therapeutics Incorporated

NASDAQ:PRLD

Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.

The Conversation (0)
MARKETS
COMMODITIES
CURRENCIES